Auranofin

CHEMBL1366 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
678.5 g/mol
LogP
Phase
4

An oral gold-containing compound originally developed for rheumatoid arthritis that reduces joint inflammation by modulating immune cell activity. It is now being investigated for its ability to induce oxidative stress in cancer cells and inhibit certain pathogens including HIV.

Berat Molekul

678,5000 g/mol

TPSA

115,00 Ų

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCP(CC)CC.CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+]

InChI

InChI=1S/C14H20O9S.C6H15P.Au/c1-6(15)19-5-10-11(20-7(2)16)12(21-8(3)17)13(14(24)23-10)22-9(4)18;1-4-7(5-2)6-3;/h10-14,24H,5H2,1-4H3;4-6H2,1-3H3;/q;;+1/p-1/t10-,11-,12+,13-,14+;;/m1../s1

Molecular Formula

C20H34AuO9PS

HBD / HBA

- / 10

Ikatan yang Dapat Dirotasi

12

Atom Berat

32

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

An oral gold-containing compound originally developed for rheumatoid arthritis that reduces joint inflammation by modulating immune cell activity. It is now being investigated for its ability to induce oxidative stress in cancer cells and inhibit certain pathogens including HIV.

Yes, Auranofin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1366. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 16667669. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.